Clearside Biomedical, Inc.
CLSD
$3.70
-$0.39-9.54%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 9.38M | 13.63M | 20.02M | 23.59M | 29.36M |
| Total Receivables | 816.00K | 1.54M | 507.00K | 788.00K | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 1.58M | 721.00K | 734.00K | 721.00K | 364.00K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 13.00K | 77.00K | 13.00K | 13.00K | 44.00K |
| Total Current Assets | 11.79M | 15.96M | 21.27M | 25.11M | 29.77M |
|
|
|||||
| Total Current Assets | 11.79M | 15.96M | 21.27M | 25.11M | 29.77M |
| Net Property, Plant & Equipment | 3.52M | 3.67M | 3.82M | 4.02M | 4.14M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 30.00K | 30.00K | 30.00K | 30.00K | 30.00K |
| Total Assets | 15.33M | 19.67M | 25.13M | 29.16M | 33.93M |
|
|
|||||
| Total Accounts Payable | 1.13M | 1.91M | 1.45M | 2.36M | 1.58M |
| Total Accrued Expenses | 1.54M | 2.72M | 2.97M | 2.86M | 3.70M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 381.00K | 378.00K | 375.00K | 373.00K | 370.00K |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | 225.00K |
| Total Other Current Liabilities | -- | -- | -- | -- | 225.00K |
| Total Current Liabilities | 3.05M | 5.01M | 4.79M | 5.59M | 5.87M |
|
|
|||||
| Total Current Liabilities | 3.05M | 5.01M | 4.79M | 5.59M | 5.87M |
| Long-Term Debt | 55.70M | 53.44M | 51.77M | 49.19M | 46.73M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 152.00K | 241.00K | 328.00K | 412.00K | 493.00K |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 5.17M | 6.89M | 7.09M | 8.76M | 9.12M |
| Total Liabilities | 64.07M | 65.58M | 63.98M | 63.95M | 62.22M |
|
|
|||||
| Common Stock & APIC | 319.26M | 317.59M | 316.42M | 313.18M | 312.00M |
| Retained Earnings | -367.99M | -363.50M | -355.28M | -347.97M | -340.28M |
| Treasury Stock & Other | -- | -- | -- | 5.00K | -1.00K |
| Total Common Equity | -48.73M | -45.91M | -38.86M | -34.79M | -28.29M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -48.73M | -45.91M | -38.86M | -34.79M | -28.29M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -48.73M | -45.91M | -38.86M | -34.79M | -28.29M |
|
|
|||||